Health X Platform Limited to hold 37th AGM on Sep 28, 2026 for financial year ending March 31, 2026
Health X Platform Limited will hold its 37th AGM on September 28, 2026, via VC/OAVM. The meeting will approve financial statements for the year ended March 31, 2026, and re-appoint directors. Key approvals sought include borrowing up to ₹500 Crores, authorizing loans/investments up to ₹600 Crores, and providing guarantees up to ₹200 Crores.
The AGM will discuss and seek approval for significant financial matters including borrowing limits and investment authorities, which could have a material impact on the company's future operations and financial structure.
The announcement is a routine notice for an Annual General Meeting and related business approvals, which does not inherently signal positive or negative performance.
Health X Platform Limited (formerly Sastasundar Ventures Limited) has announced its 37th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 3:00 P.M. (IST) through Video Conferencing (VC) or Other Audio Visual Means (OAVM).
The AGM will transact ordinary business, including the adoption of the Audited Financial Statements (Standalone and Consolidated) for the financial year ended March 31, 2026, and the re-appointment of Mrs. Abha Mittal as a Director who retires by rotation.
Special business at the meeting includes the re-appointment of Mrs. Anjana Dikshit as an Independent Director for a second term of five years, from November 10, 2026, to November 9, 2031. Additionally, the company seeks member approval for its overall borrowing limit, proposing to authorize the Board to borrow up to ₹500 Crores. Members will also vote on seeking approval for creating mortgages or charges on the company's assets up to the approved borrowing limits.
Furthermore, the company is seeking approval to authorize loans, guarantees, security, and investments under Section 186 of the Companies Act, 2013, with an aggregate outstanding amount not exceeding ₹600 Crores. Approval is also sought for advancing loans, providing guarantees, or security under Section 185 of the Companies Act, 2013, for an aggregate amount not exceeding ₹200 Crores to subsidiaries, associate companies, joint ventures, group entities, or other specified persons.
The notice also details the e-voting process for shareholders, with the remote e-voting period commencing on Friday, September 25, 2026, at 9:00 a.m. and concluding on Sunday, September 27, 2026, at 5:00 p.m. The cut-off date for determining voting eligibility is Monday, September 21, 2026.
What to do with a filing like this
Health X Platform Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Health X Platform Limited. Read the original for the full detail.